Francisco España

6.7k total citations
177 papers, 5.2k citations indexed

About

Francisco España is a scholar working on Hematology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Francisco España has authored 177 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 43 papers in Cancer Research and 36 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Francisco España's work include Blood Coagulation and Thrombosis Mechanisms (91 papers), Protease and Inhibitor Mechanisms (34 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (29 papers). Francisco España is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (91 papers), Protease and Inhibitor Mechanisms (34 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (29 papers). Francisco España collaborates with scholars based in Spain, United States and Netherlands. Francisco España's co-authors include Amparo Estellés, A. Estellés, Juan Gilabert–Estellés, John H. Griffin, Justo Aznar, J. Gilabert, J Aznar, Luis Ramón, Pilar Medina and Silvia Navarro and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Francisco España

174 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco España Spain 42 2.3k 1.1k 890 819 768 177 5.2k
Hartmut Weiler United States 35 2.2k 1.0× 311 0.3× 404 0.5× 775 0.9× 1.2k 1.5× 121 4.5k
Joseph P. Miletich United States 37 4.7k 2.0× 713 0.7× 782 0.9× 1.8k 2.2× 784 1.0× 59 7.2k
R Bach United States 33 2.4k 1.0× 337 0.3× 578 0.6× 334 0.4× 864 1.1× 64 4.2k
Shosaku� Nomura Japan 46 2.4k 1.0× 503 0.5× 941 1.1× 1.1k 1.4× 2.0k 2.6× 310 6.5k
Jacob H. Rand United States 40 2.9k 1.3× 144 0.1× 387 0.4× 404 0.5× 808 1.1× 125 5.8k
B. Wiman Sweden 31 1.8k 0.8× 1.8k 1.6× 1.1k 1.3× 509 0.6× 540 0.7× 68 3.8k
János Kappelmayer Hungary 31 743 0.3× 260 0.2× 506 0.6× 427 0.5× 678 0.9× 188 3.4k
Florence Toti France 35 1.4k 0.6× 613 0.6× 639 0.7× 819 1.0× 2.6k 3.4× 108 5.4k
Laszlo Bajzar Canada 27 2.5k 1.1× 649 0.6× 707 0.8× 817 1.0× 563 0.7× 38 3.5k
Junji Nishioka Japan 31 1.7k 0.8× 450 0.4× 342 0.4× 405 0.5× 533 0.7× 99 3.0k

Countries citing papers authored by Francisco España

Since Specialization
Citations

This map shows the geographic impact of Francisco España's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco España with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco España more than expected).

Fields of papers citing papers by Francisco España

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco España. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco España. The network helps show where Francisco España may publish in the future.

Co-authorship network of co-authors of Francisco España

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco España. A scholar is included among the top collaborators of Francisco España based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco España. Francisco España is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oto, Júlia, Silvia Navarro, Anders Christian Larsen, et al.. (2020). MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences. 21(3). 840–840. 33 indexed citations
2.
Oto, Júlia, Álvaro Fernández‐Pardo, Manuel Miralles, et al.. (2019). Activated protein C assays: A review. Clinica Chimica Acta. 502. 227–232. 19 indexed citations
3.
Medina, Pilar, Silvia Navarro, Amparo Estellés, et al.. (2012). Effects of oral anticoagulant therapy and haplotype 1 of the endothelial protein C receptor gene on activated protein C levels. Thrombosis and Haemostasis. 107(3). 448–457. 3 indexed citations
4.
Navarro, Silvia, Amparo Estellés, Ramón Montes, et al.. (2011). The endothelial cell protein C receptor: Its role in thrombosis. Thrombosis Research. 128(5). 410–416. 22 indexed citations
5.
6.
Zorio, Esther, Pilar Medina, J. Rueda, et al.. (2009). Insights Into the Role of microRNAs in Cardiac Diseases: From Biological Signalling to Therapeutic Targets. Cardiovascular & Hematological Agents in Medicinal Chemistry. 7(1). 82–90. 42 indexed citations
7.
Medina, Pilar, Esther Zorio, A. Estellés, et al.. (2008). The −589C>T polymorphism in the interleukin‐4 gene (IL‐4) is associated with a reduced risk of myocardial infarction in young individuals. Journal of Thrombosis and Haemostasis. 6(10). 1633–1638. 15 indexed citations
8.
Gilabert–Estellés, Juan, Luis Ramón, Francisco España, et al.. (2008). Vascular endothelial growth factor polymorphisms (−460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression. Fertility and Sterility. 92(4). 1214–1220. 40 indexed citations
9.
Navarro, Silvia, Pilar Medina, Yolanda Mira, et al.. (2008). Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation. Haematologica. 93(6). 885–891. 43 indexed citations
10.
Pascual, Sonia, Javier Irurzun, Pedro Zapater, et al.. (2008). Usefulness of surveillance programmes for early diagnosis of hepatocellular carcinoma in clinical practice. Liver International. 28(5). 682–689. 30 indexed citations
11.
Solá, Eva, Amparo Vayá, Dolores Corella, et al.. (2007). Erythrocyte Hyperaggregation in Obesity: Determining Factors and Weight Loss Influence. Obesity. 15(8). 2128–2134. 22 indexed citations
12.
Solá, Eva, Amparo Vayá, Piedad Villa, et al.. (2007). Obesity and Activated Protein C Resistance. Pathophysiology of Haemostasis and Thrombosis. 36(2). 64–68. 4 indexed citations
13.
España, Francisco, et al.. (2005). The Multifunctional Protein C System. PubMed. 3(2). 119–131. 23 indexed citations
14.
Iglesia, Pedro de la, et al.. (2000). Effectiveness and Safety of Balloon Dilation of the Papilla and the Use of an Occlusion Balloon for Clearance of Bile Duct Calculi. American Journal of Roentgenology. 174(5). 1455–1460. 52 indexed citations
15.
España, Francisco, J. Gilabert, Vicente Vicente, et al.. (1992). Activated protein C:α1-antitrypsin (APC:α1AT) complex as a marker for diagnosis of prethrombotic states. Thrombosis Research. 66(5). 499–508. 11 indexed citations
16.
17.
Gilabert, J., Francisco España, A. Estellés, & José A. Aznar. (1986). Functional and antigenic protein C and its inhibitor in normal pregnancy and preeclampsia. Thrombosis Research. 41. 162–162. 1 indexed citations
18.
Villa, Piedad, Amparo Estellés, J L Pérez-Requejo, Francisco España, & Justo Aznar. (1985). Possible Homozygous Factor VII<sup>R</sup> Disorder Associated with Fibrinolytic Hyperactivity. Acta Haematologica. 73(2). 93–96. 2 indexed citations
19.
Aznar, J, A. Estellés, V. Vila, et al.. (1984). Inherited Fibrinolytic Disorder Due to an Enhanced Plasminogen Activator Level. Thrombosis and Haemostasis. 52(2). 196–200. 29 indexed citations
20.
Aznar, J, et al.. (1978). Fletcher Factor Deficiency: Report of a New Family. Scandinavian Journal of Haematology. 21(2). 94–98. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hartmut Weiler Breakdown of academic impact, for papers by Joseph P. Miletich Breakdown of academic impact, for papers by R Bach Breakdown of academic impact, for papers by Shosaku� Nomura Breakdown of academic impact, for papers by Jacob H. Rand Breakdown of academic impact, for papers by B. Wiman Breakdown of academic impact, for papers by János Kappelmayer Breakdown of academic impact, for papers by Florence Toti Breakdown of academic impact, for papers by Laszlo Bajzar Breakdown of academic impact, for papers by Junji Nishioka
Rankless by CCL
2026